ME00162B - Procede 'origitea' de traitement prolonge des points d'acupunture visant notamment a reduire une masse corporelle excessive et a corriger la silhouette, dispositif et aiguille correspondants (et variantes) - Google Patents
Procede 'origitea' de traitement prolonge des points d'acupunture visant notamment a reduire une masse corporelle excessive et a corriger la silhouette, dispositif et aiguille correspondants (et variantes)Info
- Publication number
- ME00162B ME00162B MEP-2008-50A MEP5008A ME00162B ME 00162 B ME00162 B ME 00162B ME P5008 A MEP5008 A ME P5008A ME 00162 B ME00162 B ME 00162B
- Authority
- ME
- Montenegro
- Prior art keywords
- needle
- rod
- needle according
- head
- fastener
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 100
- 230000004936 stimulating effect Effects 0.000 title description 2
- 238000005842 biochemical reaction Methods 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
- 238000001467 acupuncture Methods 0.000 claims description 54
- 239000000725 suspension Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 15
- 238000002560 therapeutic procedure Methods 0.000 claims description 15
- 238000012937 correction Methods 0.000 claims description 11
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 11
- 239000010931 gold Substances 0.000 claims description 11
- 229910052737 gold Inorganic materials 0.000 claims description 10
- 239000004332 silver Substances 0.000 claims description 10
- 239000002184 metal Substances 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 229910052709 silver Inorganic materials 0.000 claims description 9
- 229910001092 metal group alloy Inorganic materials 0.000 claims description 8
- 229910000851 Alloy steel Inorganic materials 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 230000011514 reflex Effects 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 5
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- RKTYLMNFRDHKIL-UHFFFAOYSA-N copper;5,10,15,20-tetraphenylporphyrin-22,24-diide Chemical compound [Cu+2].C1=CC(C(=C2C=CC([N-]2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3[N-]2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 RKTYLMNFRDHKIL-UHFFFAOYSA-N 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 1
- 210000003128 head Anatomy 0.000 description 61
- 230000000694 effects Effects 0.000 description 56
- 208000008589 Obesity Diseases 0.000 description 20
- 235000020824 obesity Nutrition 0.000 description 20
- 230000037396 body weight Effects 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 17
- 230000036528 appetite Effects 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 230000001225 therapeutic effect Effects 0.000 description 13
- 235000019789 appetite Nutrition 0.000 description 12
- 230000000638 stimulation Effects 0.000 description 12
- 239000013585 weight reducing agent Substances 0.000 description 11
- 230000009471 action Effects 0.000 description 9
- 210000000577 adipose tissue Anatomy 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 102100037651 AP-2 complex subunit sigma Human genes 0.000 description 8
- 101100001789 Arabidopsis thaliana AP17 gene Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 210000003016 hypothalamus Anatomy 0.000 description 8
- 230000033001 locomotion Effects 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 7
- 230000002366 lipolytic effect Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000006978 adaptation Effects 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 229910045601 alloy Inorganic materials 0.000 description 5
- 239000000956 alloy Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000003825 pressing Methods 0.000 description 5
- 230000033764 rhythmic process Effects 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000021017 Weight Gain Diseases 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010039424 Salivary hypersecretion Diseases 0.000 description 3
- 241000746998 Tragus Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000002730 additional effect Effects 0.000 description 3
- 230000004872 arterial blood pressure Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000036387 respiratory rate Effects 0.000 description 3
- 208000026451 salivation Diseases 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 239000003351 stiffener Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010000410 Acetonaemia Diseases 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229910001316 Ag alloy Inorganic materials 0.000 description 2
- 229910001020 Au alloy Inorganic materials 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010011703 Cyanosis Diseases 0.000 description 2
- 208000007530 Essential hypertension Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000007976 Ketosis Diseases 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 206010048908 Seasonal allergy Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 208000037849 arterial hypertension Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000000739 chaotic effect Effects 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000002267 hypothalamic effect Effects 0.000 description 2
- 206010021654 increased appetite Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000002739 subcortical effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001457 vasomotor Effects 0.000 description 2
- 230000002747 voluntary effect Effects 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010065929 Cardiovascular insufficiency Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 102000009025 Endorphins Human genes 0.000 description 1
- 108010049140 Endorphins Proteins 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000015580 Increased body weight Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000005890 Neuroma Diseases 0.000 description 1
- 241001417523 Plesiopidae Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 206010047295 Ventricular hypertrophy Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 208000022371 chronic pain syndrome Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000003353 gold alloy Substances 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 235000006796 hypocaloric diet Nutrition 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 201000004338 pollen allergy Diseases 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009430 psychological distress Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000000576 supplementary effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Finger-Pressure Massage (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2005123065/14A RU2286133C1 (ru) | 2005-07-20 | 2005-07-20 | Игла для иглорефлексотерапии |
| RU2005134870/14A RU2336071C2 (ru) | 2005-11-10 | 2005-11-10 | Способ снижения избыточной массы тела и коррекции фигуры "оригитея" и игла для него |
| RU2006125777/14A RU2320311C1 (ru) | 2006-07-18 | 2006-07-18 | Способ пролонгированного воздействия на акупунктурные точки и игла (варианты) для него |
| PCT/RU2006/000385 WO2007011266A2 (fr) | 2005-07-20 | 2006-07-19 | Procede 'origitea' de traitement prolonge des points d'acupunture visant notamment a reduire une masse corporelle excessive et a corriger la silhouette, dispositif et aiguille correspondants (et variantes) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ME00162B true ME00162B (fr) | 2010-06-10 |
| MEP5008A MEP5008A (en) | 2010-06-10 |
Family
ID=43778349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-50/08A MEP5008A (en) | 2005-07-20 | 2006-07-19 | Method for prolonging the action on acupuncture points including for reducing the excessive body weight and for correcting the body, a device and a needle (variants) for carrying out saud method |
Country Status (2)
| Country | Link |
|---|---|
| ME (1) | MEP5008A (fr) |
| RS (1) | RS20080074A (fr) |
-
2006
- 2006-07-19 ME MEP-50/08A patent/MEP5008A/xx unknown
- 2006-07-19 RS RSP-2008/0074A patent/RS20080074A/sr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MEP5008A (en) | 2010-06-10 |
| RS20080074A (sr) | 2009-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20130197561A1 (en) | Method for prolonging the action on acupuncture points including for reducing the excessive body weight and for correcting the body, a device and a needle (variants) for carrying out said method | |
| JP4987149B1 (ja) | 鍼 | |
| WO2016134367A1 (fr) | Procédé et appareil pour traitement électromagnétique de sclérose en plaques | |
| US20130144319A1 (en) | Method of acupuncture and a needle for performing same | |
| RU2336071C2 (ru) | Способ снижения избыточной массы тела и коррекции фигуры "оригитея" и игла для него | |
| ME00162B (fr) | Procede 'origitea' de traitement prolonge des points d'acupunture visant notamment a reduire une masse corporelle excessive et a corriger la silhouette, dispositif et aiguille correspondants (et variantes) | |
| RU2233149C1 (ru) | Способ снижения избыточной массы тела и коррекции фигуры | |
| CN101257881B (zh) | 用于针灸反射疗法的装置 | |
| AU2012258487A1 (en) | Method for prolonging the action on acupuncture points | |
| HK1121666B (en) | A device for acupuncture reflexotherapy | |
| RU61559U1 (ru) | Игла для иглорефлексотерапии (варианты) | |
| EA010861B1 (ru) | Способ коррекции функциональных расстройств организма человека | |
| JP5128715B1 (ja) | 鍼 | |
| RU2233677C2 (ru) | Способ лечения сосудистых головных болей | |
| Gonçalves et al. | Stress prevention by modulation of autonomic nervous system (heart rate variability): A preliminary study using transcranial direct current stimulation | |
| KR101559866B1 (ko) | 비침습형 개혈침 | |
| RU2320311C1 (ru) | Способ пролонгированного воздействия на акупунктурные точки и игла (варианты) для него | |
| HK1141434B (en) | Method of acupuncture and a needle for carrying out said method | |
| AU2013200144A1 (en) | Method of Acupuncture with Prolonged Action | |
| UA4899U (uk) | Спосіб лікування вегетативно-судинної дистензії у віддаленому періоді черепно-мозкової травми |